---
title: "Alto Neuroscience, Immunovant And Other Big Stocks Moving Lower In Thursday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281520362.md"
description: "U.S. stock futures are down, with the Dow futures falling 400 points. Alto Neuroscience shares dropped 13.6% after disappointing Phase 2 trial results. Other stocks also fell in pre-market trading, including Akso Health Group (-9.4%), SharonAI Holdings (-8.8%), Progress Software (-8.3%), and Immunovant (-8.3%)."
datetime: "2026-04-02T12:02:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281520362.md)
  - [en](https://longbridge.com/en/news/281520362.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281520362.md)
---

# Alto Neuroscience, Immunovant And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 400 points on Thursday.

Shares of **Alto Neuroscience Inc** (NYSE:ANRO) fell sharply in pre-market trading after the company announced topline data from its Phase 2 proof-of-concept clinical trial evaluating ALTO-101 did not achieve statistical significant on primary electroencephalography or cognitive endpoints versus placebo.

Alto Neuroscience shares dipped 13.6% to $20.16 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

-   **Akso Health Group – ADR** (NASDAQ:AHG) fell 9.4% to $2.10 in pre-market trading.
-   **SharonAI Holdings Inc** (NASDAQ:SHAZ) fell 8.8% to $25.19 in pre-market trading. SharonAI Holdings shares jumped around 22% on Wednesday after the company announced the signing of a five-year TCV AI infrastructure agreement with ESDS Software Solutions.
-   **Progress Software Corp** (NASDAQ:PRGS) fell 8.3% to $23.00 in pre-market trading.
-   **Immunovant Inc** (NASDAQ:IMVT) fell 8.3% to $23.02 in pre-market trading as the company announced Phase 3 study results for Batoclimab in Thyroid Eye Disease (TED).
-   **Americas Gold and Silver Corporation** (NYSE:USAS) fell 8.1% to $5.14 in pre-market trading after gaining 7% on Wednesday.
-   **TRX Gold Corp** (NYSE:TRX) fell 7.2% to $1.42 in pre-market trading.
-   **Rezolve AI PLC** (NASDAQ:RZLV) fell 7% to $2.91 in pre-market trading after jumping 22% on Wednesday.
-   **Avino Silver & Gold Mines Ltd** (NYSE:ASM) fell 6% to $6.20 in pre-market trading after gaining 4% on Wednesday.

_Photo via Shutterstock_

### Related Stocks

- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [AHG.US](https://longbridge.com/en/quote/AHG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IMVT.US](https://longbridge.com/en/quote/IMVT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [ANRO.US](https://longbridge.com/en/quote/ANRO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SHAZ.US](https://longbridge.com/en/quote/SHAZ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PRGS.US](https://longbridge.com/en/quote/PRGS.US.md)

## Related News & Research

- [Immunovant reports $147.9M quarterly net loss, $902.1M cash as of Mar 31, 2026](https://longbridge.com/en/news/287056202.md)
- [Immunovant Posts Wider FY26 Loss, Advances IMVT-1402 Pipeline; Stock Up](https://longbridge.com/en/news/287065251.md)
- [BMY Stock Rises as Bristol Myers Brings Anthropic's Claude AI to 30,000 Employees](https://longbridge.com/en/news/287076466.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)